Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial. (2021)
Attributed to:
Advanced Pain Discovery Platform (APDP) Programme Director
funded by
SPF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.41674
PubMed Identifier: 33538113
Publication URI: http://europepmc.org/abstract/MED/33538113
Type: Journal Article/Review
Volume: 73
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
Issue: 7
ISSN: 2326-5191